The U.S. Food and Drug Administration (FDA) is working with healthcare providers, manufacturers, organizations that set standards, and other government agencies to reduce the risk of infection from the inadequate “reprocessing” of medical devices such as clamps, forceps and endoscopes, that are reused in common surgical and diagnostic procedures.
The FDA has received reports of patients being exposed to microscopic amounts of blood, body fluids and tissue from other patients that may have occurred because the reusable devices were inadequately reprocessed and these contaminants were not removed.
Transmission of infection was extremely rare, but the potential for becoming infected by an inadequately processed device was there.
Read more at: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm284636.htm
Source: U.S. Food and Drug Administration
Health Affairs Challenges Systemic Racism in Health Care
October 2nd 2023The October issue of Health Affairs examines the multifaceted aspects of structural racism in health care, exploring historical roots, policy implications, public biases, innovative solutions, and institutional challenges, urging action to confront and dismantle disparities.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Scientists Whose Work on mRNA Allowed Development of COVID-19 Vaccines Win Nobel Prize
October 2nd 2023Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."
Read More
2 Clarke Drive
Cranbury, NJ 08512